In accordance with Article 13 of Law No. 104-12 on freedom of prices and competition and Article 10 of Decree No. 2-14-652 issued for its implementation, as amended and supplemented, the Competition Council makes available to the public the \u201coperation summary\u201d below, containing the information provided by the parties.<\/p>\n
This information has been prepared by the notifying parties, who are solely responsible. Any inaccurate or distorted information contained therein does not in any way prejudge the Competition Council’s position on the proposed operation.<\/p>\n
The publication of this press release does not attest to the completeness of the file provided for in Article 9 of Decree No. 2-14-652 issued for the implementation of Law No. 104-12 on freedom of prices and competition, as amended and supplemented.<\/p>\n
Names of the companies and groups concerned<\/strong><\/p>\n Nature of the operation<\/strong><\/p>\n Economic sectors concerned<\/strong><\/p>\n Deadline for interested third parties to submit their observations<\/strong><\/p>\n NON-CONFIDENTIAL SUMMARY OF THE OPERATION PROVIDED BY THE PARTIES<\/strong><\/p>\n The Competition Council has received notification of an economic concentration operation concerning the exclusive takeover by the company \u201cMerck KGaA\u201d of the company \u201cBio-Techne Corporation\u201d, through the acquisition of all its capital and related voting rights.<\/p>\n \u201cMerck KGaA\u201d<\/strong> is a German partnership limited by shares, headquartered at Frankfurter Stra\u00dfe 250, 64293 Darmstadt, Germany. It is listed on the Frankfurt Stock Exchange under the symbol \u201cMRK\u201d. It is active in the life sciences sector through its Life Science activity, which is mainly focused on providing products and technologies for biopharmaceutical manufacturing, also offering a range of laboratory consumables used in various research processes.<\/p>\n \u201cBio-Techne Corporation\u201d<\/strong> is a Minnesota corporation, headquartered at 614 McKinley Place N.E., Minneapolis, Minnesota 55413, United States. It is listed on NASDAQ under the symbol \u201cTECH\u201d. \u201cBio-Techne Corporation\u201d operates in the life sciences sector and specializes in providing research reagents, analysis instruments, and precision diagnostic solutions, primarily for university researchers, biopharmaceutical companies, and clinical laboratories.<\/p>\n <\/p>\n Done in Rabat on September 10, 2026<\/p>\n","protected":false},"excerpt":{"rendered":" In accordance with Article 13 of Law No. 104-12 on freedom of prices and competition and Article 10 of Decree No. 2-14-652 issued for its implementation, as amended and supplemented, the Competition Council makes available to the public the \u201coperation summary\u201d below, containing the information provided by the parties. This information has been prepared by the notifying parties, who are solely responsible. Any inaccurate or distorted information contained therein does not in any way prejudge the Competition Council’s position on the proposed operation. The publication of this press release does not attest to the completeness of the file provided for in Article 9 of Decree No. 2-14-652 issued for the implementation of Law No. 104-12 on freedom of prices and competition, as amended and supplemented. Names of the companies and groups concerned The acquirer: the company \u201cMerck KGaA\u201d; The target: the company \u201cBio-Techne Corporation\u201d. Nature of the operation Exclusive takeover. Economic sectors concerned Market for the supply of products related to reagents, consumables, and analysis instruments for life sciences. Deadline for interested third parties to submit their observations 10 days from the date of publication of this press release, i.e., September 21, 2026. NON-CONFIDENTIAL SUMMARY OF THE OPERATION PROVIDED BY THE PARTIES The Competition Council has received notification of an economic concentration operation concerning the exclusive takeover by the company \u201cMerck KGaA\u201d of the company \u201cBio-Techne Corporation\u201d, through the acquisition of all its capital and related voting rights. \u201cMerck KGaA\u201d is a German partnership limited by shares, headquartered at Frankfurter Stra\u00dfe 250, 64293 Darmstadt, Germany. It is listed on the Frankfurt Stock Exchange under the symbol \u201cMRK\u201d. It is active in the life sciences sector through its Life Science activity, which is mainly focused on providing products and technologies for biopharmaceutical manufacturing, also offering a range of laboratory consumables used in various research processes. \u201cBio-Techne Corporation\u201d is a Minnesota corporation, headquartered at 614 McKinley Place N.E., Minneapolis, Minnesota 55413, United States. It is listed on NASDAQ under the symbol \u201cTECH\u201d. \u201cBio-Techne Corporation\u201d operates in the life sciences sector and specializes in providing research reagents, analysis instruments, and precision diagnostic solutions, primarily for university researchers, biopharmaceutical companies, and clinical laboratories. Done in Rabat on September 10, 2026<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[352],"tags":[],"class_list":["post-48835","post","type-post","status-publish","format-standard","hentry","category-press-releases"],"acf":[],"yoast_head":"\n\n
\n
\n
\n